If you liked this article you might like

EY's Greene Sees More Med Tech, CRO Deals Ahead
Valeant Takes Haircut on 2013 Obagi Deal as Debt Pile Looms, Divestitures Continue
President Trump Taps Randal Quarles for Federal Reserve Board
Valeant Continues Quest to Repay Massive $30 Billion Debt Load, Shares Close Higher